With the increasing prevalence of skin cancer, there are multiple options for patients, through which they can manage the disease. The type of treatment the patient receives may depend on the cancer stage the patient has. For decades, the conventional anti-cancer treatment strategies have been surger y, chemotherapy, and radiotherapy. The recent years’ success of cancer immunotherapy, including monoclonal antibodies (mAbs), adoptive cancer therapy, and the immune checkpoint therapy, has revolutionized the traditional cancer treatment. Currently, there are several studies going on to develop the vaccine for skin cancer. For instance, researchers at Tel Aviv University, Israel, have developed a novel nano-vaccine for melanoma (2019). As of now, their innovative approach has been proven effective in the mouse model. This approach has given an opportunity for the innovation companies to establish their market presence in the near future, with the help of providing a vaccine for skin cancer.

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

5. MARKET SEGMENTATION

6. COMPANY PROFILES AND COMPETITIVE LANDSCAPE

7. MARKET OPPORTUNITIES AND FUTURE TRENDS